KEI Databases
Transparency
Memorandum on measures to include data on the costs of trials in ClinicalTrials.Gov
Clinicaltrials-dot-Gov-HHS-15Sep2023 From the memo: This memo provides a request that the Department of Health and Human Services (HHS), working through the National Institutes of Health (NIH), use its rulemaking authority for ClinicalTrials.Gov to include data on the costs of human… Continue Reading
WHO Global vaccine market report (2022) flags transparency and vaccine inequity
In May 2023, the World Health Organization (WHO) published the global vaccine market report. Underpinning this technical report on vaccine market dynamics was a strong push by WHO’s Director-General, Tedros Adhanom Ghebreyesus, for increased transparency and equity; transparency is mentioned… Continue Reading
KEI Comment on the Reduction of Number of Days the Public Can Comment on a Prospective NIH Exclusive Patent License
The National Institute of Health (NIH) recently held an all-day workshop titled, “Transforming Discoveries Into Products: Maximizing NIH’s Levers to Catalyze Technology Transfer.” KEI Director James Love participated in the July 31st workshop, speaking on the panel on “How NIH… Continue Reading
Chile (on behalf of 62 countries) asks for a more transparent, inclusive process for civil society engagement in WHO negotiations of a pandemic treaty
On Monday, 17 July 2023, Chile, on behalf of a group of 62 WHO member states called for a more transparent, inclusive process for civil society engagement in the WHO negotiations of a pandemic treaty at the Intergovernmental Negotiating Body… Continue Reading
New EU AI legislation
On the fourteenth of June, the European parliament passed sweeping legislation on the regulation of artificial intelligence. The parliament’s position was backed with an overwhelming majority of 499 votes in favor and 28 against, with 93 abstentions. The legislation, which… Continue Reading
KEI response to NTIA request for comments on AI Accountability Policy, expressing concerns over trade agreement provisions which limit the transparency of source code and algorithms
KEI-NTIA-AI-Accountability-RFC KEI response to NTIA request for comments on AI Accountability Policy, expressing concerns over trade agreement provisions which limit the transparency of source code and algorithms RE: Notice by the National Telecommunications and Information Administration on 04/13/2023, Document Citation:… Continue Reading
WHA 76: KEI statement on The World Together: Establishment of an intergovernmental negotiating body to strengthen pandemic prevention, preparedness and response (decision SSA2(5) (2021))
On Friday, 26 May 2023, Knowledge Ecology International (KEI) delivered the following statement on WHO negotiations on a pandemic treaty. KEI makes 3 points on the INB negotiations. First, There needs to be less secrecy of the INB negotiations on… Continue Reading
KEI Testimony regarding the opportunities to use differential USPTO fees to achieve additional social objectives
KEI-USPTO-fees18may2023 Testimony of James Love Representing Knowledge Ecology International (KEI) regarding the opportunities to use differential USPTO fees to achieve additional social objectives USPTO Patent Public Advisory Committee Public Hearing on the Proposed Patent Fee Schedule May 18, 2023 Introduction… Continue Reading
Media coverage of the WHO pandemic treaty negotiations (on transparency and content) – First quarter, 2023
Media coverage of the WHO pandemic treaty negotiations (on transparency and content) – March/April 2023 2 February 2023, Reuters, Draft WHO pandemic deal pushes for equity to avoid COVID ‘failure’ repeat, By Jennifer Rigby and Gabrielle Tétrault-Farber. However, there will… Continue Reading